Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CACTUX in Incurable Head and Neck Squamous Cell Carcinoma
NCT02270814Phase 2Active, not recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2015
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in head and neck squamous cell carcinoma (HNSCC), sponsored by Washington University School of Medicine. Started Feb 2015; status: active, not recruiting.
02
Drugs
paclitaxel
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02270814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02270814.